Literature DB >> 18490586

Family history as a risk factor for herpes zoster: a case-control study.

Lindsey D Hicks1, Robert H Cook-Norris, Natalia Mendoza, Vandana Madkan, Anita Arora, Stephen K Tyring.   

Abstract

OBJECTIVE: To assess risk factors for herpes zoster beyond age and immunosuppression, especially the association with a family history of herpes zoster, since a preventative herpes zoster and postherpetic neuralgia vaccine is now available.
DESIGN: We undertook a case-control study of herpes zoster, which represents reactivation of latent varicella zoster virus residing in dorsal root ganglia following primary infection, involving 504 patients and 523 controls. Interviews were conducted by trained medical investigators using a structured questionnaire.
SETTING: The Center for Clinical Studies, an outpatient clinic and research center in Houston, Texas. PARTICIPANTS: Nonimmunocompromised patients with confirmed cases of herpes zoster were included in the study. Controls were nonimmunocompromised clinic patients with new diagnoses of skin diseases other than herpes zoster.
RESULTS: Cases were more likely to report blood relatives with a history of zoster (39%) compared with controls (11%; P < .001). Risk was increased with multiple blood relatives (odds ratio, 13.77; 95% confidence interval, 5.85-32.39) compared with single blood relatives (odds ratio, 4.50; 95% confidence interval, 3.15-6.41).
CONCLUSIONS: The results suggest an association between herpes zoster and family history of zoster. Future studies will be needed to investigate this association.

Entities:  

Mesh:

Year:  2008        PMID: 18490586     DOI: 10.1001/archderm.144.5.603

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  23 in total

1.  Herpes zoster recurrences more frequent than previously reported.

Authors:  Barbara P Yawn; Peter C Wollan; Marge J Kurland; Jennifer L St Sauver; Patricia Saddier
Journal:  Mayo Clin Proc       Date:  2011-01-10       Impact factor: 7.616

2.  Family history of zoster and risk of developing herpes zoster.

Authors:  Hung Fu Tseng; Margaret Chi; Peggy Hung; Rafael Harpaz; D Scott Schmid; Philip LaRussa; Lina S Sy; Yi Luo; Kimberly Holmquist; Harpreet Takhar; Steven J Jacobsen
Journal:  Int J Infect Dis       Date:  2017-11-13       Impact factor: 3.623

3.  Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of postherpetic neuralgia.

Authors:  Pieter Meysman; Benson Ogunjimi; Stefan Naulaerts; Philippe Beutels; Viggo Van Tendeloo; Kris Laukens
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

Review 4.  Advances in the understanding of the pathogenesis and epidemiology of herpes zoster.

Authors:  Anne A Gershon; Michael D Gershon; Judith Breuer; Myron J Levin; Anne Louise Oaklander; Paul D Griffiths
Journal:  J Clin Virol       Date:  2010-05       Impact factor: 3.168

5.  Vibrio vulnificus necrotizing fasciitis preceding herpes zoster.

Authors:  Kelli Y Ha; Stephen K Tyring
Journal:  Proc (Bayl Univ Med Cent)       Date:  2013-01

6.  Compliance with herpes zoster vaccination in young and adult individuals in two regions of Italy.

Authors:  Antonino Parlato; Vincenzo Romano Spica; Massimo Ciccozzi; Francesca Farchi; Francesca Gallè; Valeria Di Onofrio; Elisabetta Franco; Giorgio Liguori
Journal:  BMC Public Health       Date:  2010-06-12       Impact factor: 3.295

Review 7.  Clinical practice: Herpes zoster.

Authors:  Jeffrey I Cohen
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

Review 8.  Vaccines for preventing herpes zoster in older adults.

Authors:  Anna M Z Gagliardi; Brenda N G Andriolo; Maria R Torloni; Bernardo G O Soares
Journal:  Cochrane Database Syst Rev       Date:  2016-03-03

9.  Vaccines for preventing herpes zoster in older adults.

Authors:  Anna Mz Gagliardi; Brenda Ng Andriolo; Maria Regina Torloni; Bernardo Go Soares; Juliana de Oliveira Gomes; Regis B Andriolo; Eduardo Canteiro Cruz
Journal:  Cochrane Database Syst Rev       Date:  2019-11-07

10.  The risk of a subsequent cancer diagnosis after herpes zoster infection: primary care database study.

Authors:  S J Cotton; J Belcher; P Rose; S K Jagadeesan; R D Neal
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.